James E. Fickenscher
2020 - Zynerba Pharmaceuticals
In 2020, James E. Fickenscher earned a total compensation of $886.6K as CFO and VP, Corporate Development at Zynerba Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $129,129 |
|---|---|
| Option Awards | $303,775 |
| Salary | $409,932 |
| Other | $43,763 |
| Total | $886,599 |
Fickenscher received $409.9K in salary, accounting for 46% of the total pay in 2020.
Fickenscher also received $129.1K in non-equity incentive plan, $303.8K in option awards and $43.8K in other compensation.
Rankings
In 2020, James E. Fickenscher's compensation ranked 9,107th out of 13,090 executives tracked by ExecPay. In other words, Fickenscher earned more than 30.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,107 out of 13,090 | 30th |
Division Manufacturing | 3,890 out of 5,621 | 31st |
Major group Chemicals And Allied Products | 1,574 out of 2,254 | 30th |
Industry group Drugs | 1,377 out of 1,954 | 30th |
Industry Pharmaceutical Preparations | 1,018 out of 1,459 | 30th |
Source: SEC filing on April 21, 2021.
Fickenscher's colleagues
We found two more compensation records of executives who worked with James E. Fickenscher at Zynerba Pharmaceuticals in 2020.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019